In an era of mounting geopolitical tension, American banks find themselves entwined in a $9 billion conundrum connected to Syngenta’s imminent initial public offering (IPO) in China. This record-breaking Shanghai IPO, once seen as a golden ticket for institutions like Goldman Sachs and JPMorgan, has now turned into an intricate puzzle, with geopolitical complexities threatening ... Read more